The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Eosinophils are predominant effector cells not only in allergic diseases but also in connective tissue diseases. The recruitment of eosinophils to the site of inflammation and release of reactive oxygen species leading to tissue damage and propagation of the inflammatory response are mediated by chemokines. Thus, agents that would be able to inhibit or antagonize chemokine‐induced eosinophil activation are interesting as therapeutical agents. We describe the effect of a chemokine receptor antagonist, Met‐RANTES, on human eosinophil effector functions in response to RANTES, monocyte chemoattractant protein (MCP)‐3 and eotaxin. Met‐RANTES was able to inhibit dose‐dependently [Ca 2+]i transients in eosinophils following stimulation with RANTES, MCP‐3 and eotaxin. Whereas maximal and half‐maximal inhibitory effect of Met‐RANTES following stimulation with RANTES and MCP‐3 were observed at 2 μg/ml and 1 μg/ml, respectively, maximal and half‐maximal inhibitory effects of Met‐RANTES in response to eotaxin were detected at 10 μg/ml and 3 μg/ml. Moreover, eotaxin‐induced [Ca 2+]i transients were only half reduced at a Met‐RANTES concentration at which RANTES and MCP‐3 were completely blocked. Besides its effect on [Ca 2+]i transients, Met‐RANTES dose‐dependently inhibited actin polymerization in eosinophils following chemokine stimulation. Whereas Met‐RANTES totally inhibited RANTES‐ and MCP‐3‐induced actin polymerization at 5 μg/ml, the eotaxin‐induced response was only reduced by 50%. However, Met‐RANTES inhibited dose‐dependently the release of reactive oxygen species in response to RANTES, MCP‐3 and eotaxin. Again, eotaxin‐induced release of reactive oxygen species, however, was only half reduced at a Met‐RANTES concentration (10 μg/ml) at which RANTES and MCP‐3 were completely blocked. The results of this study show that (1) Met‐RANTES is an effective and powerful antagonist of effector functions of human eosinophils following stimulation with RANTES, MCP‐3 and eotaxin; (2) Met‐RANTES seems to be able to antagonize the response of eosinophils through chemokine receptor 1 (CCR1) preferentially to CCR3; (3) Met‐RANTES antagonizes eosinophil but not neutrophil effector functions and might be therefore of interest for a new therapeutical approach to prevent the invasion and destructive power of eosinophils in diseases that are accompanied by eosinophil infiltration such as allergic asthma and connective tissue diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bieber, T., de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R., Ring, J., Hanau, D., & de la Salle, C. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1285 · Cited by 481
Neutrophil-activating properties of the melanoma growth-stimulatory activity.
Moser, B., Clark-Lewis, I., Zwahlen, R., & Baggiolini, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1797 · Cited by 285
Cited by
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Eosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
New insights into the role of cytokines in asthma
Renauld, J.-C. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.8.577 · Cited by 384
Metadata
- Authors
- Elsner, J., Petering, H., Höchstetter, R., Kimmig, D., Wells, T. N. C., Kapp, A., & Proudfoot, A. E. J.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 27
- Issue
- 11
- Pages
- 2892-2898
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2050439545
- Cited by
- 127
- References
- 2
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.